MedTrace Logo

Provider Skill Building for Engagement and Communication in Healthcare - Hypertension Management

NCT07147075 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2026-01-29

No results posted yet for this study

Summary

Brief Summary:

The study has three main goals: The first goal is to make a skills training program that improves how doctors talk with, listen to, and work with patients. The second goal is to make sure the process of collecting data and completing the program can be done. The third goal is to make sure the skills training program is feasible and acceptable for doctors.

Study Activities:

* Doctors will first complete a questionnaire and have their patients' appointments audio-recorded.
* Then they will go through the training program.
* After finishing the program, doctors will have more patient appointments audio-recorded.
* Then the doctors will complete questionnaires again and have an interview with the study team.

Conditions

  • Patient-centered Care

Interventions

OTHER

REACH - Hypertension

The intervention is a skills training program for doctors that includes 3 self-paced on-line learning modules and 3 coaching sessions (one in-person and 2 virtual).

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • Investigator, PhD · Duke University

  • Investigator, MD · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-02
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07147075 on ClinicalTrials.gov